Related Experiment Video
Updated: May 31, 2026
04:30
Quantifying the Modulation of Elastase Enzyme Activity Through Colorimetric Analysis
Published on: January 17, 2025
Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease
Gerard M Turino1, Shuren Ma, Yong Y Lin
1St. Luke’s-Roosevelt Hospital, Pulmonary Medicine, 1000 Tenth Avenue, New York, New York 10019, USA. gmt1@columbia.edu
Summary
New biomarkers for chronic obstructive pulmonary disease (COPD) are needed. Elastin degradation products, desmosine and isodesmosine, show promise for tracking COPD severity and treatment response.
Area of Science:
- Pulmonary Medicine
- Biomarker Discovery
- Matrix Biology
Background:
- Chronic obstructive pulmonary disease (COPD) is a leading cause of death globally and in the US.
- Current therapies do not halt COPD progression or improve survival.
- Novel biomarkers are crucial for assessing disease severity and therapeutic efficacy.
Purpose of the Study:
- To evaluate elastin degradation products as potential biomarkers for COPD.
- To review evidence linking desmosine and isodesmosine to COPD progression and treatment.
Main Methods:
- Analysis of laboratory and clinical data on elastin degradation products.
- Measurement of desmosine and isodesmosine in plasma, urine, and sputum.
- Correlation of biomarker levels with COPD severity and treatment outcomes.
Main Results:
- Elastin is a key site of injury in COPD.
- Desmosine and isodesmosine are specific markers of elastin breakdown.
- Sputum levels of these biomarkers reflect lung-specific elastin degradation.
- Decades of clinical data show correlations between desmosine/isodesmosine and COPD severity/treatment response.
Conclusions:
- Elastin degradation products (desmosine and isodesmosine) represent promising biomarkers for COPD.
- These biomarkers can indicate disease severity and response to therapy.
- Further research into these markers could advance COPD management and drug discovery.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:12Elastin is Responsible for Tissue Elasticity
Elastic fiber contains the protein elastin along with lesser amounts of other proteins and glycoproteins. The main property of elastin is that it will return to its original shape after being stretched or compressed. Elastic fibers are prominent in elastic tissues found in skin and the elastic ligaments of the vertebral column.
Ligaments and tendons are made of dense regular connective tissue, but in ligaments not all fibers are parallel. Dense regular elastic tissue contains elastin fibers and...
Ligaments and tendons are made of dense regular connective tissue, but in ligaments not all fibers are parallel. Dense regular elastic tissue contains elastin fibers and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...